Vasopressin in cardiovascular patients: therapeutic implications

Author： Zimmerman Michael A   Albright Tracy N   Raeburn Christopher D   Selzman Craig H  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.5, 2002-05, pp. : 505-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Genomics of Cardiovascular Disorders: Therapeutic Implications

By Ferrari P.  

Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. : 1025-1042

Adis International

Access to resources Recommend Favorite

The therapeutic implications of oestrogens in cardiovascular diseases

By Manassiev N.   Rilwan A.   Stevenson J.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 173-188

Informa Healthcare

Access to resources Recommend Favorite

Urocortin: Cardiovascular Actions and Therapeutic Implications

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 2, 2004-04 ,pp. : 168-172

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Aleglitazar, a New Dual PPAR-α/γ Agonist: Implications for Cardiovascular Disease in Patients with Diabetes Mellitus

By Cavender Matthew A.   Lincoff A. Michael  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 4, 2010-08 ,pp. : 209-216

Adis International

Access to resources Recommend Favorite

Cardiovascular Disease and Therapeutic Drug-Related Cardiovascular Consequences in HIV-Infected Patients

By Fisher Stacy D.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 383-394

Adis International

Access to resources Recommend Favorite